Study to find new antibodies in autoimmune encephalitis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This research study looks for new markers in the blood of people with autoimmune encephalitis (a condition where the immune system attacks the brain). It aims to better understand what causes the disease and find new ways to diagnose it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able to agree to take part in the study.
- You must have a diagnosis of autoimmune encephalitis, including types with certain antibodies or Susac syndrome, but no other autoimmune disease.
- If you are in the control group, you must not have these types of encephalitis or antibodies.
- If you are in the control group, you must have another brain disorder and have tested negative for certain brain-related antibodies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information from people with autoimmune encephalitis, a condition where the body's immune system attacks the brain. It aims to understand the disease better, and if you have seizures from it, you can join a special epilepsy part.
This study is testing a new lab test that may help doctors more accurately diagnose GABABR antibody encephalitis, a type of brain inflammation. The test looks for certain antibodies in your blood or spinal fluid.
This study looks at how the immune system works in certain neurological conditions, including autoimmune encephalitis and related nerve disorders. Researchers may use blood and/or spinal fluid samples, especially when antibodies are present or can’t be found, to better understand what’s driving the illness.
This study tests a natural bile-derived medicine (Calcus Bovis Sativus) to see if it can help adults with new or recent brain inflammation (encephalitis). It focuses on people whose encephalitis is caused by the immune system or a virus, and who have not fully recovered.
This study tests a new medicine (ART5803) in people whose immune system attacks a brain receptor called NMDAR, causing encephalitis (brain swelling) or psychiatric symptoms. It aims to see if the medicine can reduce symptoms like confusion, memory problems, or psychosis.
This study tests whether a nasal spray containing stem cell products can help people recover from autoimmune encephalitis, a condition where the body's immune system attacks the brain. It may reduce symptoms like confusion, memory problems, or seizures.
Hear when a new Autoimmune Encephalitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.